Business | Press Trust of India | Monday July 18, 2016
Sun Pharma Advanced Research Company (SPARC) and its parent Sun Pharma have entered into a licensing arrangement for its Elepsia tablets, used in the treatment of epilepsy, in the US market for an up-front payment of $10 million.
www.ndtv.com/business